Milk Thistle

botanicalmagnesium dihydroxide

What is it

Milk thistle (Silybum marianum) is a flowering plant native to the Mediterranean region, cultivated since ancient Greek and Roman times. Its seeds contain a complex of flavonolignans collectively called silymarin, which is the bioactive standardized extract used for liver-related applications.

How it works

Silymarin is actually a complex of related compounds, the most active of which are silybin (also called silibinin), isosilybin, silychristin, and silydianin. Silybin alone accounts for roughly 60 to 70 percent of silymarin's activity. The proposed mechanisms include direct antioxidant activity in hepatocytes, stabilization of liver cell membranes against toxins, stimulation of hepatic protein synthesis and regeneration, and inhibition of fibrosis pathways implicated in chronic liver disease. Silymarin has been used most extensively for treatment of Amanita phalloides (death cap mushroom) poisoning, where intravenous silybin (Legalon SIL) is an established part of treatment protocols in many European countries. For chronic liver conditions (cirrhosis, viral hepatitis, NAFLD, drug-induced liver injury), oral silymarin shows more variable and often modest effects in clinical trials. Bioavailability of standard silymarin is poor; phytosomal formulations (silymarin bound to phosphatidylcholine, sold as Siliphos or similar) substantially improve absorption.

Evidence for 6 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Amanita mushroom poisoning (medical use)

Grade B

Good evidence

IV silybin (Legalon SIL) is established hepatic protection in Amanita phalloides poisoning protocols in much of Europe and is increasingly available in the US under expanded access. Hospital-administered, not consumer use.

Alcoholic liver disease

Grade C

Moderate evidence

Trials of silymarin (420 to 800 mg/day) in alcoholic cirrhosis have shown mixed results. Some show improvements in liver enzymes and modest survival benefit; others show no effect. The strongest predictor of outcome is alcohol cessation, not silymarin.

Non-alcoholic fatty liver disease (NAFLD)

Grade C

Moderate evidence

Trials of 420 mg/day silymarin or higher have shown reductions in liver enzymes (ALT, AST) and modest improvements in liver fat in adults with NAFLD. Effects on histology are smaller. Lifestyle changes remain the cornerstone.

Drug-induced liver injury

Grade C

Moderate evidence

Trials of silymarin as adjunct to chemotherapy and antitubercular therapy have shown reductions in liver enzyme elevations in some studies. Mechanism is plausible but evidence remains modest.

Chronic viral hepatitis

Grade C

Moderate evidence

Trials in chronic hepatitis B and C have shown variable effects on liver enzymes and quality of life. Effects on viral load and disease progression are limited.

Type 2 diabetes glycemic control

Grade C

Moderate evidence

Trials of silymarin (200 to 600 mg/day) have shown modest reductions in fasting blood glucose and HbA1c in adults with type 2 diabetes. Not a substitute for diabetes medications.

4 commercial forms

Standardized silymarin extract (80 percent flavonolignans)

Standardized to silymarin content; oral bioavailability of silybin is poor.

Most common consumer form. 200 to 600 mg/day typical.

Siliphos (silybin phytosome)

Silybin complexed with phosphatidylcholine; 5 to 10 times higher plasma silybin than standard.

Most absorbable oral form. Lower doses produce equivalent effects.

Whole milk thistle seed

Lowest silymarin content; high fiber.

Traditional whole-food form. Used as 1 to 2 tsp ground seeds per day.

IV silybin (Legalon SIL)

Complete delivery; hospital use only.

Used for Amanita mushroom poisoning. Not consumer-available.

Dosage

Typical doses of standardized silymarin extract are 200 to 600 mg per day, divided into 2 or 3 doses. Trials for chronic liver disease have used 420 to 800 mg/day for 2 to 12 months. Phytosomal formulations achieve equivalent plasma silybin at lower doses (200 to 400 mg/day). IV silybin for mushroom poisoning uses much higher hospital-administered doses.

When and how to take it

Take milk thistle with meals to improve absorption of the fat-soluble silymarin flavonolignans. Splitting daily totals (200 to 300 mg twice daily) maintains steadier plasma levels than a single large dose. Phytosomal formulations are more absorbable and may require lower doses. Effects on liver enzymes and disease markers typically build over 8 to 12 weeks. Milk thistle is not stimulating; evening dosing is fine.

Food sources

FoodAmount%DV
Milk thistle seeds (1 tsp ground)minimal silymarin content; concentrated extracts preferred

Safety

Milk thistle is generally well tolerated. Side effects are uncommon and mild: GI upset (nausea, gas, diarrhea), headache, and rare allergic reactions, particularly in people with allergies to other Asteraceae plants (ragweed, daisies, chrysanthemums). No formal Tolerable Upper Intake Level has been established. Long-term safety has been studied up to 5 years in chronic liver disease trials with no major signals. Pregnancy and breastfeeding have limited data; some traditional use exists but caution is warranted. Milk thistle may modestly lower blood glucose. It has mild estrogenic effects in some lab studies, which is theoretically relevant for hormone-sensitive cancers.

Who should be cautious

Avoid with allergies to plants in the Asteraceae family (ragweed, daisies, chrysanthemums). Use cautiously with hormone-sensitive cancers (breast, prostate, ovarian, uterine, endometriosis, fibroids) due to theoretical estrogenic effects. Coordinate with prescribers if on drugs metabolized by CYP3A4 or CYP2C9. Pregnancy and breastfeeding: consult clinician. Children should not use without guidance.

Interactions

Milk thistle affects various CYP450 enzymes (especially CYP2C9 and CYP3A4), potentially altering metabolism of many drugs. May modestly increase the effect of antidiabetic medications (blood sugar monitoring advised). May affect levels of statins, anticoagulants, and antipsychotics through CYP interactions. Theoretical estrogen-receptor activity may interact with hormone-sensitive cancer treatments. Generally well tolerated alongside common medications at typical doses.

Frequently asked questions

Will milk thistle protect my liver from alcohol?

No reliable evidence supports milk thistle as a pre-drinking 'liver protector.' Trials in active alcoholic liver disease show mixed and modest results. Stopping or reducing drinking is dramatically more effective than any supplement.

Is milk thistle the same as silymarin?

Silymarin is the active flavonolignan complex extracted from milk thistle seeds, accounting for most of its effects. Standardized milk thistle supplements typically contain 80 percent silymarin. Silybin is the most active single component within silymarin.

How long until milk thistle works?

Effects on liver enzymes typically build over 8 to 12 weeks. Acute single-dose effects are minimal. Don't expect to feel different after a few days.

Can I take milk thistle with my medications?

Coordinate with your prescriber. Milk thistle affects CYP450 enzymes (especially CYP3A4 and CYP2C9), which metabolize many medications. Most common drugs are not meaningfully affected, but check with your pharmacist.

Is the phytosomal version worth the extra cost?

For people with serious liver concerns, the substantially better absorption of phytosomal silymarin (Siliphos) may justify the cost. For general liver support, standard silymarin extract is reasonable and well-studied.

References

  • Wikidata: Milk ThistleWikidata link

Track Milk Thistle with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you're pregnant, breastfeeding, on medications, or managing a chronic condition.